Showing results 3 to 3 of 3
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Recombinant α2 interferon is superior to doxorubin for inoperable hepatocellular carcinoma: A prospective randomised trial Journal:British Journal of Cancer | 1989 |